Neurogene's stock {$NGNE} fell 35% in post-market trading on Monday after a Rett syndrome patient who received a high dose of ...
Me is closing its therapeutics division and will wind down ongoing clinical trials, the struggling genetic testing company ...
Rapt Therapeutics is officially shelving its mid-stage immunology candidate after a case of liver failure triggered clinical ...
Thermo Fisher is closing a factory in Lexington, MA, and merging operations with a newer facility in Plainville, MA, to ...
The FDA has removed a clinical hold on Novavax’s flu-Covid combination shot and standalone flu vaccine, less than a month ...
The centerpiece of AbbVie’s $8.7 billion Cerevel acquisition just imploded. Emraclidine, a schizophrenia program expected to ...
Glucagon-like peptide-1 (GLP-1) receptor agonists have gained attention as potential treatments for a variety of ...
Cigna said it will not pursue a merger with rival Humana after reports last month of renewed talks about a potential deal. Talks of a deal ...
Assertio Holdings responded to activist investor Alexander Parker after Parker's firm accused Assertio of fraud. The Buxton Helmsley Group on Friday released an open letter to Assertio’s stockholders, ...
The eye giant Alcon has launched an unlikely legal battle, suing a cell therapy startup that it invested in and claiming its shareholder rights are being violated as Aurion Biotech ...
SAN ANTONIO — Well behind Novo Nordisk and Eli Lilly in the obesity race, AstraZeneca came to this year’s ...
Biogen brings in medical chief as CFO plans retirement; MacroGenics CEO announces departure
Michael McDonnell is retiring as CFO of Biogen on Feb. 28, and Chris Viehbacher’s crew has lined up chief accounting officer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback